rs3213926
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015295.3(SMCHD1):c.5476+10A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.302 in 1,465,200 control chromosomes in the GnomAD database, including 69,465 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.29 ( 6737 hom., cov: 33)
Exomes 𝑓: 0.30 ( 62728 hom. )
Consequence
SMCHD1
NM_015295.3 intron
NM_015295.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.337
Publications
9 publications found
Genes affected
SMCHD1 (HGNC:29090): (structural maintenance of chromosomes flexible hinge domain containing 1) This gene encodes a protein which contains a hinge region domain found in members of the SMC (structural maintenance of chromosomes) protein family. [provided by RefSeq, Dec 2011]
SMCHD1 Gene-Disease associations (from GenCC):
- arhinia, choanal atresia, and microphthalmiaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics, ClinGen, Illumina
- facioscapulohumeral muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 18-2777925-A-G is Benign according to our data. Variant chr18-2777925-A-G is described in ClinVar as Benign. ClinVar VariationId is 260654.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.492 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMCHD1 | NM_015295.3 | c.5476+10A>G | intron_variant | Intron 43 of 47 | ENST00000320876.11 | NP_056110.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMCHD1 | ENST00000320876.11 | c.5476+10A>G | intron_variant | Intron 43 of 47 | 5 | NM_015295.3 | ENSP00000326603.7 |
Frequencies
GnomAD3 genomes AF: 0.292 AC: 44402AN: 151986Hom.: 6725 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
44402
AN:
151986
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.344 AC: 48452AN: 140654 AF XY: 0.346 show subpopulations
GnomAD2 exomes
AF:
AC:
48452
AN:
140654
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.303 AC: 397439AN: 1313096Hom.: 62728 Cov.: 20 AF XY: 0.305 AC XY: 198031AN XY: 648844 show subpopulations
GnomAD4 exome
AF:
AC:
397439
AN:
1313096
Hom.:
Cov.:
20
AF XY:
AC XY:
198031
AN XY:
648844
show subpopulations
African (AFR)
AF:
AC:
6985
AN:
29132
American (AMR)
AF:
AC:
13121
AN:
29840
Ashkenazi Jewish (ASJ)
AF:
AC:
7699
AN:
23734
East Asian (EAS)
AF:
AC:
16493
AN:
35110
South Asian (SAS)
AF:
AC:
30215
AN:
71272
European-Finnish (FIN)
AF:
AC:
12867
AN:
48600
Middle Eastern (MID)
AF:
AC:
1448
AN:
5444
European-Non Finnish (NFE)
AF:
AC:
291042
AN:
1015046
Other (OTH)
AF:
AC:
17569
AN:
54918
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
12754
25509
38263
51018
63772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
9946
19892
29838
39784
49730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.292 AC: 44442AN: 152104Hom.: 6737 Cov.: 33 AF XY: 0.294 AC XY: 21851AN XY: 74352 show subpopulations
GnomAD4 genome
AF:
AC:
44442
AN:
152104
Hom.:
Cov.:
33
AF XY:
AC XY:
21851
AN XY:
74352
show subpopulations
African (AFR)
AF:
AC:
10118
AN:
41524
American (AMR)
AF:
AC:
5483
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1098
AN:
3470
East Asian (EAS)
AF:
AC:
2629
AN:
5174
South Asian (SAS)
AF:
AC:
2075
AN:
4818
European-Finnish (FIN)
AF:
AC:
2802
AN:
10558
Middle Eastern (MID)
AF:
AC:
73
AN:
294
European-Non Finnish (NFE)
AF:
AC:
19111
AN:
67970
Other (OTH)
AF:
AC:
637
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1623
3246
4869
6492
8115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
468
936
1404
1872
2340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1689
AN:
3466
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 24, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Facioscapulohumeral muscular dystrophy 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Arrhinia with choanal atresia and microphthalmia syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.